Received Apr 30, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | T5727 | — |
pediatric dose administered instead of adult dose; underdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of adult use of a child product in a 44-year-old male patient who received HAV (Havrix 720) (batch number T5727, expiry date 06-MAY-2026) for prophylaxis. On 21-APR-2026, the patient received Havrix 720. On 21-APR-2026, an unknown time after receiving Havrix 720, the patient experienced adult use of a child product (Verbatim: pediatric dose administered instead of adult dose) and underdose (Verbatim: underdose). The outcome of the adult use of a child product and underdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.